3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
6
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Multiple Myeloma
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hypogonadism
1
Head and Neck Neoplasms
1
Cognitive/Functional Effects
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
pembrolizumab
1
neratinib
1
cemiplimab
1
brigatinib
1
Watchful Waiting
1
Vincristine
1
Vemurafenib
1
Temozolomide
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Mental Status and Dementia Tests
×
90 days
×
Clear all
No trials found.